Abstract:Pluripotent stem cells of the mammalian epiblast and their cultured counterparts—embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs)—have the capacity to differentiate in all cell types of adult organisms. An artificial process of reactivation of the pluripotency program in terminally differentiated cells was established in 2006, which allowed for the generation of induced pluripotent stem cells (iPSCs). This iPSC technology has become an invaluable tool in investigating the molecular mechanisms of human diseases and therapeutic drug development, and it also holds tremendous promise for iPSC applications in regenerative medicine. Since the process of induced reprogramming of differentiated cells to a pluripotent state was discovered, many questions about the molecular mechanisms involved in this process have been clarified. Studies conducted over the past 2 decades have established that metabolic pathways and retrograde mitochondrial signals are involved in the regulation of various aspects of stem cell biology, including differentiation, pluripotency acquisition, and maintenance. During the reprogramming process, cells undergo major transformations, progressing through three distinct stages that are regulated by different signaling pathways, transcription factor networks, and inputs from metabolic pathways. Among the main metabolic features of this process, representing a switch from the dominance of oxidative phosphorylation to aerobic glycolysis and anabolic processes, are many critical stage-specific metabolic signals that control the path of differentiated cells toward a pluripotent state. In this review, we discuss the achievements in the current understanding of the molecular mechanisms of processes controlled by metabolic pathways, and vice versa, during the reprogramming process.

A Reversible Neural Stem Cell Quiescence and Activation Culture System for Metabolic Study

The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance

Energy Metabolism Plays A Critical Role In Stem Cell Maintenance And Differentiation

Metabolism Regulation of Phenotypic and Therapeutic Properties of Human Mesenchymal Stem Cells

Bioenergetic shifts during transitions between stem cell states (2013 Grover Conference series).

Ex Vivo Expansion, Adipogenesis And Neurogenesis Of Cyropreserved Human Bone Marrow Mesenchymal Stem Cells

Metabolic and proteostatic differences in quiescent and active neural stem cells

Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms

Metabolic Regulation of Mesenchymal Stem Cell in Expansion and Therapeutic Application

Stem cell quiescence and its clinical relevance

Metabolic Reconfiguration Supports Reacquisition of Primitive Phenotype in Human Mesenchymal Stem Cell Aggregates.

Changing and stable chromatin accessibility supports transcriptional overhaul during neural stem cell activation and is altered with age

Quiescent neural stem cells transiently become 'neurons' to coordinate reactivation

Metabolic Regulation: A Potential Strategy for Rescuing Stem Cell Senescence

Emerging Functional Connections Between Metabolism and Epigenetic Remodeling in Neural Differentiation

Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain

Metabolic control of induced pluripotency

Impact of Metabolic Pathways and Epigenetics on Neural Stem Cells

NAD+/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro

MITOCHONDRIAL METABOLIC CHECKPOINT, STEM CELL AGING AND REJUVENATION

Notch signaling blockade links transcriptome heterogeneity in quiescent neural stem cells with their reactivation routes and potential